TOKYO, Sept. 15, 2025 /PRNewswire/ — The highly popular social entertainment app WePlay announced today that, to express gratitude for users’ longstanding support, it has invited the iconic Japanese anime IP “CHIBI MARUKO-CHAN” to join its anniversary celebration lineup.

Maruko Joins WePlay for a Surprise Party

From 12:00 PM on September 16 to 12:00 AM on September 26, Maruko will appear as a virtual guest for the very first time on WePlay’s voice rooms. She will interact closely with players, sharing cheerful greetings and delightful surprises. Maruko’s signature smile and everyday stories will bring a warm, healing vibe to the WePlay community.

Exclusive Fourth Anniversary Rewards

• Exclusive Maruko Virtual Gifts: Specially designed collectible items to make your interactions even more meaningful.
• Exclusive CHIBI MARUKO-CHAN avatar: Use the exclusive avatar to transform into Maruko and join the anniversary celebration;
• Will’s Birthday Surprise Party: Spend a heartwarming online celebration with Will and CHIBI MARUKO-CHAN.

CHIBI MARUKO-CHAN: A Beloved Cultural Icon

Originally created by Momoko Sakura, CHIBI MARUKO-CHAN is set in Shimizu City, Shizuoka Prefecture (now Shimizu Ward, Shizuoka City), and warmly depicts the everyday life of the Sakura family—especially Maruko, the second daughter and a third-grade elementary school student—as well as her family and friends. The series began serialization in Ribon (SHUEISHA) in 1986 and celebrated its 35th anniversary in 2021.

The television anime adaptation began airing in 1990 and is still broadcast every Sunday at 6 p.m. on the Fuji TV network. The show has also been broadcast in Greater China and many other regions, captivating audiences of all ages around the world and continuing to be beloved for generations.

Four Years of Connection, Same Original Mission

Since launching in Japan four years ago, WePlay has remained committed to creating fun, heartwarming, and diverse social experiences. Through this anniversary celebration, WePlay aims to deliver more surprises and lasting memories while embarking on the next exciting chapter together with its community.

About WePlay

WePlay, a global social entertainment platform under Singapore-based Wejoy, integrates games, entertainment, and social features. With a mission to “Bring joy and friends to young people around the world,” WePlay is committed to co-create an innovative era of gaming and social experiences.

Contact：qipeinan@wejoysg.com
Website：https://weplayapp.com/

SHENZHEN, China, Sept. 15, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for large-scale genomic research, the T7+ delivers more than 14 Tb/day of data in just 24 hours while offering a smaller footprint, flexible run configurations, and end-to-end automation. Internally dubbed a “data mining machine,” the T7+ redefines high-throughput sequencing by combining daily output with ease of use and multi-omics versatility.

A New Era in High-Throughput Sequencing

The T7+ integrates MGI’s proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The compact system supports 1–4 flow cells per run, adapts to projects of any scale, and integrates every step—from DNB preparation to bioinformatics analysis—into a fully automated workflow.

Key technical highlights include:

• Throughput: More than 14 Tb/day (vs. 7 Tb/day on T7)
• Annual Capacity: Up to 35,000 whole-genome sequencing (WGS)
• Accuracy: >90% Q40 quality scores, validated in beta testing by leading labs
• Speed: PE150 reads in under 24 hours
• Flexibility: Configurable for mid- or large-scale studies
• Size Efficiency: 1 m²
• 7-in-1 Integration: Hardware + software architecture eliminates manual preparation steps
• Scanning Time: 50% reduced by the TDI(Time-Delay Integration) camera.
• One-Stop Workflow: Built-in automation from DNB preparation to bioinformatics
• Reduced energy consumption: Over 90% of transport links and certain reagents require no cold chain.

With these capabilities, the T7+ enables researchers to sequence 144 human genomes in a single day, accelerating breakthroughs in cancer genomics, rare disease research, and precision medicine.

From T7 to T7+: Continuing the T Series Legacy

The DNBSEQ-T7, launched in 2018, was a breakthrough in the T Series, setting a new benchmark for high-throughput sequencing by delivering up to 7 terabases (Tb) of data in 24 hours. With over 400 units installed at more than 200 leading institutions worldwide, such as national initiatives, including Thailand’s Genomics Thailand Initiative and Brazil’s largest genomic sequencing project. This milestone redefined sequencing speed and accessibility, cementing the T Series as a cornerstone of genomic innovation.

As sequencing becomes increasingly affordable, researchers are demanding instruments that deliver higher throughput, faster results, and uncompromising accuracy and quality. That’s why MGI developed the T7+, an advanced continuation of the T7 designed to deliver greater speed, scalability, high flexibility, and performance to meet the evolving demands of clinical research, population genomics, and large-scale sequencing projects.

T7 was a breakthrough in specs, while the T7+ breaks new ground in user experience.

Redefining High-Throughput Sequencing

T7+ solves the universal trade-offs researchers face—speed versus capacity, usability versus cost. By integrating 7-in-1 hardware, smartphone-like software, and modular-designed consumables, the T7+ makes sequencing as intuitive as using a smartphone. Its ability to support multi-omics applications—spatial omics, single-cell, proteomics, methylation—in one run enables concurrent data streams for large cohorts.

“The T7+ is more than just a sequencer—it is a bridge between scientific discovery and real-world health outcomes,” added Duncan Yu, President of MGI Tech. “With higher throughput, improved accuracy, and a smaller footprint, the T7+ empowers scientists to ask bigger questions and deliver insights faster. Every genome sequenced has the potential to accelerate rare disease diagnosis, guide precision oncology, and inform public health at scale.”

Early adopters of the T7+ are already deploying it in population-scale studies, where its short-read power, combined with cyclone long-read data, enhances structural variant detection and rare disease analysis. Others are pairing the T7+ with long-read platforms for single-cell studies, opening new opportunities in understanding genetic diversity and cellular complexity.

T7+ is now open to order. International shipments begin in late 2025.

LAS VEGAS, Sept. 15, 2025  /PRNewswire/ — BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from September 8-11. As North America’s largest clean energy platform, RE+ brought together global industry leaders, where BCI (PT.BINTAN CELLULAR INDONESIA) BCI demonstrated its technological prowess in solar cells and established valuable partnerships.

The BCI booth was always crowded with visitors. BCI comprehensively displayed its product lines covering high-efficiency cells and next-generation ultra-high-efficiency technologies. Its full range of photovoltaic cells have won wide acclaim from the professional audience with their ultra-high conversion efficiency, ultra-low energy consumption design and excellent temperature coefficient performance. It is worth noting that the core products have passed a number of international authoritative tests and comply with the compliance guidelines of the North American market, providing local customers with a reliable option for quick landing.

The event generated overwhelming industry interest in BCI. Numerous potential clients engaged in in-depth discussions, expressing strong cooperation intentions. This enthusiastic response validates BCI’s technological strengths and market competitiveness in the global renewable energy sector.

BCI remains committed to driving the clean energy transition through continuous innovation. Leveraging our manufacturing base in Indonesia, we are actively strengthening the connection between Southeast Asian production capacity and the North American market. Moving forward, BCI will collaborate with global photovoltaic partners to contribute to a sustainable energy future worldwide.

LAS VEGAS, Sept. 15, 2025  /PRNewswire/ — BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from September 8-11. As North America’s largest clean energy platform, RE+ brought together global industry leaders, where BCI (PT.BINTAN CELLULAR INDONESIA) BCI demonstrated its technological prowess in solar cells and established valuable partnerships.

The BCI booth was always crowded with visitors. BCI comprehensively displayed its product lines covering high-efficiency cells and next-generation ultra-high-efficiency technologies. Its full range of photovoltaic cells have won wide acclaim from the professional audience with their ultra-high conversion efficiency, ultra-low energy consumption design and excellent temperature coefficient performance. It is worth noting that the core products have passed a number of international authoritative tests and comply with the compliance guidelines of the North American market, providing local customers with a reliable option for quick landing.

The event generated overwhelming industry interest in BCI. Numerous potential clients engaged in in-depth discussions, expressing strong cooperation intentions. This enthusiastic response validates BCI’s technological strengths and market competitiveness in the global renewable energy sector.

BCI remains committed to driving the clean energy transition through continuous innovation. Leveraging our manufacturing base in Indonesia, we are actively strengthening the connection between Southeast Asian production capacity and the North American market. Moving forward, BCI will collaborate with global photovoltaic partners to contribute to a sustainable energy future worldwide.